Sweet Inulin Tricks You Aren't Utilising

21, p?Icotinib order CEVA W PITOYO2, ZULKIFLI AMIN2 1Department of Internal Medicine, University of Indonesia, Jakarta, 2Pulmonology Division, Department of Internal Medicine, University of Indonesia, Jakarta Background?As a global health problem, COPD may contribute to significant health problems during pilgrimage for moslems. Indonesian Ministry of Health documented acute exacerbation of COPD (AECOPD) as the second leading causes of death in pilgrims with 12.3% of total mortality in 2008. Identifying individuals with higher risk to have AECOPD prior to their embarkation is essential. Therefore, the use of CAT scores in assessing risk of acute AECOPD in this special population merits further investigation. Methods?This is a cohort study recruiting 61 COPD patients at Jakarta embarkation point where patients completed CAT. Subjects and their pilgrims groups' doctors were given diary cards to record any symptoms of exacerbation during pilgrimage. On arrival at disembarkation point, subjects Inulin underwent history taking, health examination and all diary cards were collected. AECOPD were determined from the diary cards and individual health record book carried by every pilgrim. Results?All patients completed the study. Most subjects were male (57; 93.4%) with a mean age for this study is 58.8?��?8.5 years. Thirty five patients (57.4%) suffered from AECOPD during pilgrimage. CAT scores range from 0�C25 with a mean of 8.2?��?5.5. Subjects within low impact group (CAT score?check details Conclusions?This study indicates that the use of CAT may be a valuable tool in identifying individuals at risk of AECOPD prior to pilgrims' embarkation. PRISKA DUANA PUTRI, FAISAL YUNUS, TRIYA DAMAYANTI, M FAHMI ALATAS Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia, Persahabatan Hospital, Jakarta, Indonesia Background?Chronic obstructive pulmonary disease is multisystemic inflammation with high morbidity and mortality. Comorbid anemia was common in patients with chronic disease and eosinopenia as marker of inflammation has been evaluated.